MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wiens, B. L.
Right arrow Articles by Neve, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wiens, B. L.
Right arrow Articles by Neve, K. A.

Vol. 54, Issue 2, 435-444, August 1998

Contribution of Serine Residues to Constitutive and Agonist-Induced Signaling via the D2S Dopamine Receptor: Evidence for Multiple, Agonist-Specific Active Conformations

Brenda L. Wiens, Cole S. Nelson, and Kim A. Neve

Medical Research Service, Veterans Affairs Medical Center (B.L.W., K.A.N.), Departments of Behavioral Neuroscience (B.L.W., K.A.N.) and Physiology and Pharmacology (C.S.N., K.A.N.), and Center for Research on Occupational and Environmental Toxicology (C.S.N.), Oregon Health Sciences University, Portland, Oregon 97201

Dopamine D2 receptors contain a cluster of serine residues in the fifth transmembrane domain that contribute to activation of the receptor as well as to the binding of agonists. We used rat D2S dopamine receptor mutants, each containing a serine-to-alanine substitution (S193A, S194A, S197A), to investigate the mechanism through which these residues affect activation of the receptor. Activation of the mutant receptor S194A was abolished in an agonist-dependent manner, such that dopamine no longer inhibited cAMP accumulation in C6 glioma cells or activated G protein-regulated K+ channels in Xenopus laevis oocytes, whereas the efficacy of several other agonists was unaffected. Dihydrexidine did not inhibit cAMP accumulation at either S193A or S194A. The decreased efficacy of dihydrexidine at S193A and S194A and dopamine at S194A was associated with a decreased ability to detect a GTP-sensitive high affinity binding state for these agonists. The ability of dopamine to stimulate [35S]guanosine-5'-O-(3-thio)triphosphate binding via S194A also was decreased by ~50%. Finally, constitutive stimulation of [35S]guanosine-5'-O-(3-thio)triphosphate binding and inhibition of adenylate cyclase by the D2S receptor was reduced by mutation of either S193 or S194. These data support the existence of multiple active receptor conformations that are differentially sensitive to mutation of serine residues in the fifth-transmembrane domain.

Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 FASEB J.Home page
E. L. Maillet, N. Pellegrini, C. Valant, B. Bucher, M. Hibert, J.-J. Bourguignon, and J.-L. Galzi
A novel, conformation-specific allosteric inhibitor of the tachykinin NK2 receptor (NK2R) with functionally selective properties
FASEB J, July 1, 2007; 21(9): 2124 - 2134.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
W. Guo, L. Shi, M. Filizola, H. Weinstein, and J. A. Javitch
From The Cover: Crosstalk in G protein-coupled receptors: Changes at the transmembrane homodimer interface determine activation
PNAS, November 29, 2005; 102(48): 17495 - 17500.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. L. Shoemaker, M. B. Ruckle, P. R. Mayeux, and P. L. Prather
Agonist-Directed Trafficking of Response by Endocannabinoids Acting at CB2 Receptors
J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 828 - 838.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
E. A. Gay, J. D. Urban, D. E. Nichols, G. S. Oxford, and R. B. Mailman
Functional Selectivity of D2 Receptor Ligands in a Chinese Hamster Ovary hD2L Cell Line: Evidence for Induction of Ligand-Specific Receptor States
Mol. Pharmacol., July 1, 2004; 66(1): 97 - 105.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
A. Christopoulos and T. Kenakin
G Protein-Coupled Receptor Allosterism and Complexing
Pharmacol. Rev., June 1, 2002; 54(2): 323 - 374.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
C. Watson, G. Chen, P. Irving, J. Way, W.-J. Chen, and T. Kenakin
The Use of Stimulus-Biased Assay Systems to Detect Agonist-Specific Receptor Active States: Implications for the Trafficking of Receptor Stimulus by Agonists
Mol. Pharmacol., April 13, 2001; 58(6): 1230 - 1238.
[Abstract] [Full Text]

Home page
 FASEB J.Home page
T. KENAKIN
Inverse, protean, and ligand-selective agonism: matters of receptor conformation
FASEB J, March 1, 2001; 15(3): 598 - 611.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
K. Allman, K. M. Page, C. A.M. Curtis, and E. C. Hulme
Scanning Mutagenesis Identifies Amino Acid Side Chains in Transmembrane Domain 5 of the M1 Muscarinic Receptor that Participate in Binding the Acetyl Methyl Group of Acetylcholine
Mol. Pharmacol., July 1, 2000; 58(1): 175 - 184.
[Abstract] [Full Text]

Home page
 Endocr. Rev.Home page
U. Gether
Uncovering Molecular Mechanisms Involved in Activation of G Protein-Coupled Receptors
Endocr. Rev., February 1, 2000; 21(1): 90 - 113.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
R. Seifert, U. Gether, K. Wenzel-Seifert, and B. K. Kobilka
Effects of Guanine, Inosine, and Xanthine Nucleotides on beta 2-Adrenergic Receptor/Gs Interactions: Evidence for Multiple Receptor Conformations
Mol. Pharmacol., August 1, 1999; 56(2): 348 - 358.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
G. Liapakis, J. A. Ballesteros, S. Papachristou, W. C. Chan, X. Chen, and J. A. Javitch
The Forgotten Serine. A CRITICAL ROLE FOR Ser-2035.42 IN LIGAND BINDING TO AND ACTIVATION OF THE beta 2-ADRENERGIC RECEPTOR
J. Biol. Chem., November 22, 2000; 275(48): 37779 - 37788.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics